Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

30.50p
   
  • Change Today:
    -2.00p
  • 52 Week High: 67.60
  • 52 Week Low: 13.00
  • Currency: UK Pounds
  • Shares Issued: 287.30m
  • Volume: 1,040,997
  • Market Cap: £87.63m
  • RiskGrade: 479
  • Beta: 0.02

Deal with Barclays    Trade now with Barclays Stockbrokers

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
99.3% below the market average99.3% below the market average99.3% below the market average99.3% below the market average99.3% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
86.63% below the market average86.63% below the market average86.63% below the market average86.63% below the market average86.63% below the market average
46.03% below the sector average46.03% below the sector average46.03% below the sector average46.03% below the sector average46.03% below the sector average
Price Chg 3m
10.51% below the market average10.51% below the market average10.51% below the market average10.51% below the market average10.51% below the market average
49.21% above the sector average49.21% above the sector average49.21% above the sector average49.21% above the sector average49.21% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
26.93% below the market average26.93% below the market average26.93% below the market average26.93% below the market average26.93% below the market average
1.64% below the sector average1.64% below the sector average1.64% below the sector average1.64% below the sector average1.64% below the sector average
Momentum 20
27.05% below the market average27.05% below the market average27.05% below the market average27.05% below the market average27.05% below the market average
4.92% below the sector average4.92% below the sector average4.92% below the sector average4.92% below the sector average4.92% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
47.52% below the market average47.52% below the market average47.52% below the market average47.52% below the market average47.52% below the market average
20.83% below the sector average20.83% below the sector average20.83% below the sector average20.83% below the sector average20.83% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss
57.3% below the market average57.3% below the market average57.3% below the market average57.3% below the market average57.3% below the market average
10.2% below the sector average10.2% below the sector average10.2% below the sector average10.2% below the sector average10.2% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
82.58% below the market average82.58% below the market average82.58% below the market average82.58% below the market average82.58% below the market average
95.65% below the sector average95.65% below the sector average95.65% below the sector average95.65% below the sector average95.65% below the sector average
Cash
72.06% below the market average72.06% below the market average72.06% below the market average72.06% below the market average72.06% below the market average
95.92% below the sector average95.92% below the sector average95.92% below the sector average95.92% below the sector average95.92% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
58.6% below the market average58.6% below the market average58.6% below the market average58.6% below the market average58.6% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
59.40% above the market average59.40% above the market average59.40% above the market average59.40% above the market average59.40% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Futura Medical Market Data

Currency UK Pounds
Share Price 30.50p
Change Today -2.00p
% Change -6.15 %
52 Week High 67.60
52 Week Low 13.00
Volume 1,040,997
Shares Issued 287.30m
Market Cap £87.63m
Beta 0.02
RiskGrade 479

Futura Medical Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
51.74% below the market average51.74% below the market average51.74% below the market average51.74% below the market average51.74% below the market average
63.27% below the sector average63.27% below the sector average63.27% below the sector average63.27% below the sector average63.27% below the sector average
Price Trend
60.56% above the market average60.56% above the market average60.56% above the market average60.56% above the market average60.56% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Futura Medical Dividends

No dividends found

Trades for 24-Jan-2022

Time Volume / Share Price
16:35 151 @ 30.50p
16:29 531 @ 30.40p
16:29 431 @ 29.80p
16:17 50,347 @ 29.79p
16:14 3,329 @ 29.79p

Futura Medical Key Personnel

CEO James Henry Barder
Finance Director Angela Hildreth

Top of Page